← Back to Search

Audio Recordings for Diabetes Management (REPLAY Trial)

N/A
Recruiting
Led By Kerri L Cavanaugh, MD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up patient activation at 12-months from enrollment
Awards & highlights

REPLAY Trial Summary

This trial will test if adding audio recordings of clinic visits to usual care can help improve health outcomes for older adults with diabetes & other conditions.

Who is the study for?
This trial is for older adults aged 65 or above with diabetes and at least one other chronic condition, who have seen their provider twice in the past year and will continue care at the clinic. Participants must not have severe vision or hearing issues, cognitive impairments, live in nursing homes/hospice, have a history of certain mental disorders or substance abuse, lack internet access/email, or speak languages other than English/Spanish.Check my eligibility
What is being tested?
The study compares two approaches: providing patients with audio recordings of their clinic visits to help manage their health (AUDIO), versus the standard practice of giving an After Visit Summary only (Usual Care). The goal is to see if AUDIO can improve self-management in older adults with multiple health conditions including diabetes.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like audio recordings and summaries rather than drugs or medical procedures, there are no direct physical side effects expected from participating. However, participants may experience privacy concerns or technical difficulties.

REPLAY Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~patient satisfaction at 12-months from enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and patient satisfaction at 12-months from enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Activation Measure-Short Form
Secondary outcome measures
Adherence to Refills and Medications-D (ARMS-D)
Global PROMIS 10
Patient Satisfaction Questionnaire-18

REPLAY Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: AudioActive Control1 Intervention
Researchers will audio record both in-person and telehealth visits of participants in the intervention group.
Group II: Usual carePlacebo Group1 Intervention
Participants will receive Usual Care

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,549 Total Patients Enrolled
24 Trials studying Diabetes
764,590 Patients Enrolled for Diabetes
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,514 Total Patients Enrolled
24 Trials studying Diabetes
63,841 Patients Enrolled for Diabetes
Dartmouth-Hitchcock Medical CenterLead Sponsor
524 Previous Clinical Trials
2,540,453 Total Patients Enrolled
2 Trials studying Diabetes
88 Patients Enrolled for Diabetes

Media Library

Clinic visit audio recordings for self-management in older adults Clinical Trial Eligibility Overview. Trial Name: NCT05824572 — N/A
Diabetes Research Study Groups: Audio, Usual care
Diabetes Clinical Trial 2023: Clinic visit audio recordings for self-management in older adults Highlights & Side Effects. Trial Name: NCT05824572 — N/A
Clinic visit audio recordings for self-management in older adults 2023 Treatment Timeline for Medical Study. Trial Name: NCT05824572 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is registration open for this experiment?

"While the initial posting of this medicinal experiment was recorded on May 1st 2023, and last modified 19 days ago, clinicaltrials.gov indicates that it is no longer actively recruiting candidates. Fortunately, there are 182 other trials currently open to new patients."

Answered by AI
~224 spots leftby Dec 2026